SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-076435
Filing Date
2020-06-24
Accepted
2020-06-24 16:20:08
Documents
16
Period of Report
2020-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2022780-5_8k.htm   iXBRL 8-K 34277
2 EXHIBIT 1.1 tm2022780d5_ex1-1.htm EX-1.1 88973
3 EXHIBIT 4.2 tm2022780d5_ex4-2.htm EX-4.2 100697
4 EXHIBIT 5.1 tm2022780d5_ex5-1.htm EX-5.1 17647
  Complete submission text file 0001104659-20-076435.txt   510746

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA abt-20200622.xsd EX-101.SCH 3545
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abt-20200622_def.xml EX-101.DEF 28691
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE abt-20200622_lab.xml EX-101.LAB 37875
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abt-20200622_pre.xml EX-101.PRE 26910
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2022780-5_8k_htm.xml XML 5466
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 20985737
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences